Amundi
IRWD icon

Amundi’s Ironwood Pharmaceuticals IRWD Stock Holding History

Amundi’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Sell
404,237
-238,593
-37% -$978K ﹤0.01% 1183
2025
Q4 		$2.17M Buy
+642,830
New +$1.67M ﹤0.01% 1149
2025
Q3 		– Sell
-755,536
Closed -$559K – 1635
2025
Q2 		$559K Buy
755,536
+685,556
+980% +$538K ﹤0.01% 1348
2025
Q1 		$95.2K Buy
69,980
+8,001
+13% +$19.1K ﹤0.01% 1754
2024
Q4 		$284K Buy
61,979
+38,889
+168% +$158K ﹤0.01% 1671
2024
Q3 		$95.8K Buy
23,090
+2,381
+11% +$12.8K ﹤0.01% 1776
2024
Q2 		$127K Sell
20,709
-3,380
-14% -$23.9K ﹤0.01% 1674
2024
Q1 		$183K Buy
24,089
+5,197
+28% +$63.1K ﹤0.01% 1652
2023
Q4 		$236K Buy
18,892
+1,600
+9% +$15.8K ﹤0.01% 1592
2023
Q3 		$162K Sell
17,292
-53
-0.3% -$519 ﹤0.01% 1648
2023
Q2 		$180K Buy
17,345
+15,502
+841% +$167K ﹤0.01% 1627
2023
Q1 		$19.4K Hold
1,843
– – ﹤0.01% 1963
2022
Q4 		$20.7K Sell
1,843
-335,157
-99% -$3.8M ﹤0.01% 1793
2022
Q3 		$3.53M Buy
+337,000
New +$3.82M ﹤0.01% 1041

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Amundi's IRWD Position: Q1 2026 in Review

Amundi reduced its Ironwood Pharmaceuticals (IRWD) stake by 37% in Q1 2026, selling an estimated $978K and leaving 404,237 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

Amundi first reported a position in IRWD in Q3 2022 and has held it in 14 quarters since. The position peaked at $3.53M in Q3 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Amundi held 404,237 shares of Ironwood Pharmaceuticals worth $1.42M as of Q1 2026.
  • Amundi sold 238,593 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $978K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1183 holding.
  • Amundi first reported a position in Ironwood Pharmaceuticals in Q3 2022 and has held it in 14 quarters since.
  • Amundi's Ironwood Pharmaceuticals position peaked at $3.53M in Q3 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.